[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Views 10,178
Citations 0
December 18, 2013

JAMA Theme Issue on Infectious Diseases—Call for Papers

Author Affiliations
  • 1Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Ann Arbor
  • 2Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan
  • 3Associate Editor, JAMA
  • 4Deputy Editor, JAMA
JAMA. 2013;310(23):2509. doi:10.1001/jama.2013.284362

Infectious disease is among the most complex and dynamic of all medical specialties, with near-constant change in organisms, drugs, and approaches to patient care. Ironically, while advances in public health have been driven historically by management of infections, the body of evidence that guides contemporary practice in infectious diseases remains relatively limited. Many infection-related threats, such as avian influenza, extensively drug-resistant tuberculosis, and the growth of multidrug-resistant organisms with a lean pipeline for novel anti-infectives, are current concerns. Past outbreaks of SARS, pandemic influenza, Middle East respiratory syndrome coronavirus, and iatrogenic fungal meningitis are reminders that others await and, on arrival, will leave the public health and infectious diseases communities scrambling for solutions only after serious illness results.

In acknowledgment of the fundamental role infectious diseases play in contemporary health care, the JAMA editors are pleased to announce an infectious diseases theme issue for publication in October 2014, at the time of the annual IDWeek meeting. We invite authors to submit manuscripts on any topic related to the epidemiology, diagnosis, treatment, or prevention of infectious diseases. We will consider any category of study and a wide range of topics, but highest priority will be given to original research that is clinically relevant and methodologically sound, especially clinical trials that address novel approaches to treatment and prevention of common infections. Given the timing of publication of the theme issue, we are especially interested in late-breaking clinical trials that will be presented at the IDWeek meeting. Authors involved with such studies are encouraged to contact us as early as possible, both to discuss our interest in the trial and to coordinate timing of manuscript submission with the goal of simultaneous publication at the time of presentation.

Clinical trials rarely can fill a journal issue, and important clinical questions far exceed the number of trials that can be planned, so we invite authors to submit research with other designs and approaches. Translational investigations that have indirect clinical significance by advancing the understanding of pathogenesis and biomolecular aspects of disease will receive careful consideration. Studies that present new information relevant to optimizing treatment strategies and prevention efforts, and those that enhance the understanding of quality-of-life and economic consequences of infection are also of interest. We also invite submission of thought-provoking Viewpoints on timely and potentially controversial topics related to infectious diseases. Manuscripts on topics the research community is especially engaged in—novel antimicrobials, new treatments for viral hepatitis, and immunizations to prevent or modify disease—are welcome. Although human immunodeficiency virus (HIV)–related submissions are also welcome, a separate theme issue on HIV/AIDS is planned for July 2014.

Prospective authors should consult the Instructions for Authors for guidelines on manuscript preparation and submission.1 All submitted manuscripts will undergo the usual process of editorial evaluation and review. High-quality manuscripts not accepted for publication in JAMA may be referred (with the authors’ permission) to one of the JAMA Network journals for further consideration.

Authors who are interested in submitting a manuscript for the infectious diseases theme issue should indicate this on their cover letter accompanying the manuscript. Manuscripts received before April 15, 2014, will have the best chance of consideration for inclusion in the JAMA infectious diseases theme issue. Exceptions to this submission deadline can be made for late-breaking randomized clinical trials if needed.

If authors have any questions about this theme issue or any other issues related to infectious diseases–related submissions to JAMA, please feel free to contact us.

We look forward to receiving your manuscripts for the 2014 infectious diseases theme issue of JAMA.

Back to top
Article Information

Corresponding Author: Preeti N. Malani, MD, MSJ, Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, 3119 Taubman Center, Ann Arbor, MI 48109-5378 (pmalani@umich.edu).

Editorials represent the opinions of the authors and JAMA and not those of the American Medical Association.

JAMA Instructions for Authors. http://jama.jamanetwork.com/public/instructionsForAuthors.aspx. Accessed November 21, 2013.